ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer has the highest lethality among gynecological tumors. Therefore, it is essential to find reliable biomarkers to improve early detection. This is the first report describing ADAM17 detection in serum and ascites fluid of ovarian cancer patients. A high ADAM17 concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogmans, Christoph, Kuhlmann, Jan Dominik, Hugendieck, Gerrit, Link, Theresa, Arnold, Norbert, Weimer, Jörg Paul, Flörkemeier, Inken, Rambow, Anna-Christina, Lieb, Wolfgang, Maass, Nicolai, Bauerschlag, Dirk O., Hedemann, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583642/
https://www.ncbi.nlm.nih.gov/pubmed/34771725
http://dx.doi.org/10.3390/cancers13215563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583642/
https://www.ncbi.nlm.nih.gov/pubmed/34771725
http://dx.doi.org/10.3390/cancers13215563

Ejemplares similares